“…These numbers, despite a lack of treatment, are considerably close to the decolonization rates in the current study, even though all carriers in our study underwent treatment, which highlights the urgent need for careful consideration regarding the effect and possible consequences of antibiotic use in asymptomatic carriers ( 16 – 18 ). Therefore, we are currently performing a randomized, placebo-controlled, double-blind trial in adults, registered at ClinicalTrials.gov ( www.clinicaltrials.gov ) under EudraCT identifier 2019-002631-29, to determine the effect of clindamycin on MRSA throat decolonization ( 19 ).…”